Digital Biomarkers Summit · Basel · 23 June 2026 · Poster
The audio processing changed. The reading held.
Our Basel poster, June 2026: under simulated changes to a phone’s noise cancellation, handcrafted speech measures shifted though patients had not; Cephalgo’s multi‑stream reading stayed stable and still distinguished patients from controls.
When the device changes mid‑trial: evaluating speech‑based digital endpoint robustness to on‑device preprocessing variability in longitudinal remote monitoring
- Conference
- 9th annual Digital Biomarkers in Clinical Trials Summit, hosted in partnership with Roche
- Date
- Tuesday 23 June 2026
- Venue
- Roche Building 1, Grenzacherstrasse 124, Basel, Switzerland
- Data
- A public Parkinson’s speech dataset, Parkinson’s disease versus healthy controls
A silent change that can look like disease
The same recordings were processed several ways and each model was held fixed, so any movement in a reading came from the processing alone.
The audio changes first
A software update can change a phone’s built‑in noise cancellation. The audio changes, and speech measures computed from it can shift though the patient has not changed.
Easy to mistake for progression
In a long study the shift arrives without warning and can look like real disease change. A single type of speech measure cannot tell the two apart.
Stable, and still distinguishes patients from controls
Cephalgo’s multi‑stream reading combines linguistic, acoustic and learned audio streams. It was the only approach tested that stayed stable across recording conditions and also distinguished patients from controls well.
Handcrafted measures moved with the processing
Handcrafted acoustic measures still distinguished patients from controls, but their output followed the processing change.
Check the measures you rely on
If your trial records speech over months, a phone or software change can move your endpoint while the patient stays the same. The check runs on recordings you already hold, beside your current endpoint.
A stability audit
Where phone or software changes can enter your study, and whether your current speech measures move with them. Stability audit ›
Audio from a trial you already ran
A re‑analysis pilot reads recordings you already hold, on your trial’s own scale. Re‑analysis pilot ›
Your device plan
Separate from this poster: how Cephalgo keeps readings on one scale when phones or their software change, with study phones or BYOD. Device changes ›
Parkinson’s programs
What Cephalgo reads in de novo and early Parkinson’s trials. Parkinson’s ›
From Copenhagen to Boston
Five posters in 2026, from explainable screening in Copenhagen to phone and software changes in Basel, Philadelphia and Boston.
- March 2026
AD/PD™ 2026, Copenhagen · two ePosters
Validation of fully explainable speech biomarkers for AD/MCI screening, and for PD/HC screening
More about these ePosters › - June 2026
Digital Biomarkers in Clinical Trials Summit, Basel
When the device changes mid‑trial: evaluating speech‑based digital endpoint robustness to on‑device preprocessing variability in longitudinal remote monitoring
You are here - September 2026
ISCTM Autumn Conference, Philadelphia
When the device changes mid‑trial: speech‑based digital endpoint robustness to on‑device preprocessing variability
More about this poster › - November 2026
CTAD 2026, Boston · P446
Noise‑cancellation variability as a source of longitudinal drift in speech‑based digital endpoints for Alzheimer’s disease trials
More about this poster ›
